{"name":"Biokine Therapeutics Ltd","slug":"biokine-therapeutics-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPVkxNdDJJWHdEbjRZeTJyYmU1blJDR2NMcWQySGRXbzd3dXhybWZJT3pRcUtGOU0zMmFadG9zY0NHS21ZT0dJUTZ5WEowa1VjMlhhZmdOT0N5TXhKS0M0cndvcUtOUTY2eG5wc1Z1SVFQVUI4Z3Q0RVpZMGV1VXpkelVhS0h4dlJXd24wZlRZZk1DV1UyRi1DWGd2SXNOUTN3UVZ1OUtlS3FaUkdRLUhWTDNkOGJOUWxxbjM0Zw?oc=5","date":"2026-03-27","type":"pipeline","source":"Stock Titan","summary":"BioLineRx (NASDAQ: BLRX) files Form 20-F/A to correct auditor consent - Stock Titan","headline":"BioLineRx (NASDAQ: BLRX) files Form 20-F/A to correct auditor consent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQbVladVBMRXRrZzAydEx1bWR0bURJeXBCbFh4UkJHb1ZZX1JYa3NzWlpSRGFvUnpXWVM4cmtoR25QQXR2TGlKTjhfTjY3NlZON0tyUVBxYy16MVJMcGdlLWFaUUJ3eVE1c2Rid1ZQc2NmbnMzdmRDTldxb2hCZmsyOUw2Ti1UMy1iNVlBbGpFWF9qeTJvMnQwQm9YRnBVOXFBeWE3c2ZoaC00M1o2WnBMQm1ZRGMxUExVdUw2WFRiMHBzc0xNMU40c3VFX3QtU291X1NnQmlkYTVrX1YyX3R6RkdBZFo5RzU4Z0ZXUzBILWtGcmJXbU4ydVJnTklzOC0tS3ZfTFloWWdfNm9wcFdMVWhaRmJ2VE1IdXgzUzh2cjAzS1Y1?oc=5","date":"2025-02-21","type":"pipeline","source":"GlobeNewswire","summary":"Cell and Gene Therapies in Rare Disorders Market to - GlobeNewswire","headline":"Cell and Gene Therapies in Rare Disorders Market to","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}